Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-31 @ 9:29 PM
Study NCT ID:
NCT06456593
Status:
RECRUITING
Last Update Posted:
2025-09-18
First Post:
2024-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Sponsor:
Abivax S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABX464-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None